{
    "abstract": "To investigate the efficacy and safety of laparoscopic pyeloplasty combined with ultrasonic lithotripsy via nephroscope in the treatment of ureteropelvic junction obstruction (UPJO) with renal calculi.\nFrom June 2016 to January 2022, eight patients including five males and three females underwent laparoscopic pyeloplasty combined with ultrasonic lithotripsy via 19.5F(1F\u22480.33 mm) nephroscope in Peking University People' s Hospital. The age ranged from 23-51 years (mean: 40.5 years) and the body mass index (BMI) ranged from 18.8-32.4 kg/m\nSurgery was successfully completed in all of the eight patients without conversion to open surgery. The operation time ranged from 160-254 min (mean 213 min) and the time of nephroscopic management time was 25-40 min (mean: 33 min). The hemoglobin was decreased by 3-21 g/L (mean: 10.3 g/L). The stone-free rate was 75% (6/8 cases), stones were incompletely removed in two patients due to abnormal intrarenal structure. The modified Clavien classification system (MCCS) grade \u2162A complication occurred in one patient postoperatively, which was nephrosis due to intrarenal bleeding, and nephrostomy was performed. With the mean follow-up of 30 months (ranged from 2-68 months), there was no evidence of obstruction in all the patients, and one patient underwent percutaneous nephrolithotomy to treat residual calculi.\nLaparoscopic pyeloplasty combined with ultrasonic lithotripsy via 19.5F nephroscope is feasible and safe, and could be a complementary method to treat UPJO and renal calculi.\n\u63a2\u8ba8\u5e94\u7528\u8179\u8154\u955c\u80be\u76c2\u6210\u5f62\u672f\u8054\u5408\u80be\u76c2\u955c\u8d85\u58f0\u788e\u77f3\u53d6\u77f3\u672f\u6cbb\u7597\u80be\u76c2\u8f93\u5c3f\u7ba1\u8fde\u63a5\u90e8\u6897\u963b(ureteropelvic junction obstruction\uff0cUPJO)\u5408\u5e76\u80be\u7ed3\u77f3\u7684\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u3002\n\u56de\u987e\u6027\u5206\u6790\u5317\u4eac\u5927\u5b66\u4eba\u6c11\u533b\u96622016\u5e746\u6708\u81f32022\u5e741\u6708\u63a5\u53d7\u8be5\u672f\u5f0f\u6cbb\u7597\u76848\u4f8b\u60a3\u8005\u7684\u4e34\u5e8a\u8d44\u6599\uff0c\u7537\u60275\u4f8b\uff0c\u5973\u60273\u4f8b\uff0c\u5e73\u5747\u5e74\u9f8440.5\u5c81(23~51\u5c81)\uff0c\u5e73\u5747\u4f53\u91cd\u6307\u6570(body mass index\uff0cBMI)27.0 kg/m\n\u5168\u90e8\u60a3\u8005\u7684\u624b\u672f\u5747\u987a\u5229\u5b8c\u6210\uff0c\u65e0\u4e2d\u8f6c\u5f00\u653e\u624b\u672f\uff0c\u5e73\u5747\u624b\u672f\u65f6\u95f4213 min (160~254 min)\uff0c\u5e73\u5747\u80be\u955c\u64cd\u4f5c\u65f6\u95f433 min (25~40 min)\u3002\u672f\u540e\u7b2c1\u5929\u8840\u7ea2\u86cb\u767d\u5e73\u5747\u4e0b\u964d10.3 g/L (3~21 g/L)\u3002\u672f\u540e\u51c0\u77f3\u7387\u4e3a75%(6/8\u4f8b)\u3002\u7ecf\u6539\u826fClavien\u5206\u7ea7\u7cfb\u7edf(modified Clavien classification system\uff0cMCCS)\u8bc4\u4f30\uff0c\u2162A\u7ea7\u5e76\u53d1\u75c71\u4f8b\uff0c\u4e3a\u80be\u76c2\u5185\u51fa\u8840\u5bfc\u81f4\u80be\u79ef\u6c34\uff0c\u4e88\u5c40\u90e8\u9ebb\u9189\u4e0b\u884c\u80be\u9020\u7618\u672f\u540e\u6cbb\u6108\u3002\u5e73\u5747\u968f\u8bbf30\u4e2a\u6708(2~68\u4e2a\u6708)\uff0c\u80be\u76c2\u6210\u5f62\u624b\u672f\u6210\u529f\u7387\u4e3a100%\uff0c1\u4f8b\u60a3\u8005\u56e0\u7ed3\u77f3\u589e\u591a\u884c\u7ecf\u76ae\u80be\u955c\u53d6\u77f3\uff0c\u5176\u4f59\u60a3\u8005\u672a\u89c1\u7ed3\u77f3\u590d\u53d1\u6216\u589e\u591a\u3002\n\u8179\u8154\u955c\u80be\u76c2\u6210\u5f62\u672f\u8054\u5408\u80be\u76c2\u955c\u8d85\u58f0\u788e\u77f3\u53d6\u77f3\u672f\u6cbb\u7597UPJO\u5408\u5e76\u80be\u7ed3\u77f3\u5b89\u5168\u3001\u6709\u6548\uff0c\u64cd\u4f5c\u6027\u597d\uff0c\u53ef\u4f5c\u4e3a\u73b0\u884c\u53d6\u77f3\u65b9\u5f0f\u7684\u8865\u5145\u3002",
    "authors": [
        {
            "affiliation": "Urology and Lithotripsy Center, Peking University People' s Hospital, Peking University Applied Lithotripsy Institute, Beijing 100034, China.",
            "firstname": "L Z",
            "initials": "LZ",
            "lastname": "An"
        },
        {
            "affiliation": "Urology and Lithotripsy Center, Peking University People' s Hospital, Peking University Applied Lithotripsy Institute, Beijing 100034, China.",
            "firstname": "L L",
            "initials": "LL",
            "lastname": "Xiong"
        },
        {
            "affiliation": "Urology and Lithotripsy Center, Peking University People' s Hospital, Peking University Applied Lithotripsy Institute, Beijing 100034, China.",
            "firstname": "L",
            "initials": "L",
            "lastname": "Chen"
        },
        {
            "affiliation": "Urology and Lithotripsy Center, Peking University People' s Hospital, Peking University Applied Lithotripsy Institute, Beijing 100034, China.",
            "firstname": "H R",
            "initials": "HR",
            "lastname": "Wang"
        },
        {
            "affiliation": "Urology and Lithotripsy Center, Peking University People' s Hospital, Peking University Applied Lithotripsy Institute, Beijing 100034, China.",
            "firstname": "W N",
            "initials": "WN",
            "lastname": "Chen"
        },
        {
            "affiliation": "Urology and Lithotripsy Center, Peking University People' s Hospital, Peking University Applied Lithotripsy Institute, Beijing 100034, China.",
            "firstname": "X B",
            "initials": "XB",
            "lastname": "Huang"
        }
    ],
    "conclusions": "Laparoscopic pyeloplasty combined with ultrasonic lithotripsy via 19.5F nephroscope is feasible and safe, and could be a complementary method to treat UPJO and renal calculi.",
    "copyrights": null,
    "doi": "10.19723/j.issn.1671-167X.2022.04.026\n10.1007/s00240-014-0736-2\n10.1016/S0022-5347(01)63922-3\n10.1016/j.juro.2008.06.020\n10.1016/S0302-2838(03)00297-5\n10.1016/j.juro.2008.06.024\n10.1159/000127347\n10.1089/end.2008.0003\n10.1111/j.1464-410X.2005.05819.x\n10.1080/21681805.2017.1300188\n10.3760/cma.j.cn112330-20200530-00006\n10.1016/j.urology.2014.09.031\n10.1007/s00345-009-0469-y\n10.1007/s00345-018-2608-9\n10.1016/j.urology.2003.09.049\n10.1016/j.eururo.2005.11.025\n10.3969/j.issn.1671-167X.2015.04.017\n10.1089/end.2008.9726\n10.1016/S0022-5347(17)35898-6\n10.1016/S0022-5347(05)65276-7\n10.1016/j.urology.2005.11.024\n10.1016/S0022-5347(05)65305-0\n10.1159/000495569\n10.3760/cma.j.issn.1000-6702.2019.09.008",
    "journal": "Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences",
    "keywords": [
        "Kidney calculi",
        "Laparoscopy",
        "Pyeloplasty",
        "Ureteropelvic junction obstruction"
    ],
    "methods": null,
    "publication_date": "2022-08-12",
    "pubmed_id": "35950402\n25362543\n9649242\n18707717\n12932933\n18707739\n18480637\n18578658\n16287459\n28398101\n25530399\n19711084\n30661106\n1512824\n14972459\n16457941\n26284400\n18831672\n8230507\n11832708\n16635516\n11832737\n30630187\n0",
    "results": "Surgery was successfully completed in all of the eight patients without conversion to open surgery. The operation time ranged from 160-254 min (mean 213 min) and the time of nephroscopic management time was 25-40 min (mean: 33 min). The hemoglobin was decreased by 3-21 g/L (mean: 10.3 g/L). The stone-free rate was 75% (6/8 cases), stones were incompletely removed in two patients due to abnormal intrarenal structure. The modified Clavien classification system (MCCS) grade \u2162A complication occurred in one patient postoperatively, which was nephrosis due to intrarenal bleeding, and nephrostomy was performed. With the mean follow-up of 30 months (ranged from 2-68 months), there was no evidence of obstruction in all the patients, and one patient underwent percutaneous nephrolithotomy to treat residual calculi.",
    "title": "[Laparoscopic pyeloplasty combined with ultrasonic lithotripsy via nephroscope for treatment of ureteropelvic junction obstruction with renal calculi].",
    "xml": "<Element 'PubmedArticle' at 0x7885053e4db0>"
}